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Background: The storage duration of red blood cells transfused to critically ill patients is associated with increased
morbidity and mortality. Whether the association exists between storage duration of red blood cells transfused to
patients with sepsis and the risk of developing ALI/ARDS is unknown. We aimed to determine the association of
the storage duration of red blood cells transfused to patients with sepsis and risk of developing acute lung injury in
the subsequent 96 hours, with comparator trauma and nonsepsis/nontrauma groups.
Methods: We conducted a retrospective observational study of 96 transfused, critically ill patients with sepsis, 176
transfused, critically ill patients with traumatic injury, and 125 transfused, critically ill nontrauma, nonsepsis patients.
The primary outcome was the development of ALI/ARDS up to 96 hours after transfusion.
Results: In 96 patients with sepsis, 49 (51%) patients developed ALI/ARDS. The median storage duration of
transfused blood in the ALI/ARDS group was greater (24.5 days, interquartile range (IQR) 20–31) compared with the
patients who did not develop ALI/ARDS (21 days, IQR 15–27, p = 0.018). Longer median storage duration was
independently associated with an increased risk of developing ALI/ARDS in the subsequent 4 days (odds ratio 1.8,
p = 0.028). The same association was not seen in the trauma or nonsepsis, nontrauma patients.
Conclusions: Transfusion of blood with longer median storage duration to patients with sepsis is associated with a
higher risk of developing ALI up to 4 days after transfusion. This same association is not seen in other critically ill
patient populations.
Keywords: Acute respiratory distress syndrome; Transfusion-related acute lung injury; Red blood cell storage lesionBackground
Anemia is a common problem in critically ill patients
and is ubiquitous in those remaining in an ICU for more
than 2 days. The treatment of anemia in the ICU in-
cludes transfusion of red blood cells (RBCs) and may be
used in as many as 40% of patients [1-3]. The practice of
RBC transfusion to critically ill patients has recently
come under scrutiny. Data have emerged describing the
potential negative impact that RBC transfusion may have
on outcomes, including increased ICU length of stay [4],* Correspondence: david.janz@vanderbilt.edu
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in any medium, provided the original work is pnosocomial infections [5], multiorgan failure [6], acute
lung injury [7-11], and mortality [2,12,13]. The patho-
physiology underlying these adverse outcomes is not clear,
but a growing body of data suggests a relationship with
the storage duration of RBCs. With longer storage dur-
ation, there is an accumulation in the stored unit of
biologically active lipids able to prime neutrophils [14,15],
proinflammatory cytokines, such as IL-1, IL-8, TNF-α
[16], procoagulant microparticles [17], and oxidants, in-
cluding free hemoglobin and isoprostanes [18]. Con-
sequently, longer storage duration of RBCs has been
associated with some of the same adverse outcomes in
humans, including multiorgan failure and increased risk of
mortality [19-25], along with acute lung injury in animals
[26-29]. However, the potential effect of storage durationOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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not been systematically investigated nor is it known
whether the risk of ALI related to storage duration of
RBCs is consistent across different critically ill patient
populations.
Based on the theoretical “two-hit hypothesis” for the
development of transfusion-related ALI wherein neutro-
phils are initially primed by a risk factor (i.e., sepsis) and
then activated by components of transfused blood
[14,30], patients with sepsis who are exposed to RBCs
may be a population at increased risk for ALI after
transfusion with blood of a long storage duration. We
performed a retrospective observational study to test the
hypothesis that the storage duration of transfused blood
is associated with an increased risk of developing ALI up
to 96 hours after exposure in patients with sepsis. For
comparison, we conducted similar analyses in patients
with severe trauma and critically ill patients without
trauma or sepsis.
Methods
Study design and patient population
The study population consisted of 1,334 patients who
were enrolled prospectively in the Validating Acute Lung
Injury Markers for Diagnosis (VALID) study [31-34] be-
tween January 1, 2008 and December 31, 2010. Although
patients were enrolled in the VALID study beginning in
2006, electronically accessible blood bank records were
not available prior to January 1, 2008. The VALID study
aims to identify and validate plasma biomarkers for the
diagnosis of ALI and includes patients who are ≥18 years
old admitted to the Vanderbilt University Medical Cen-
ter medical, surgical, cardiovascular, or trauma ICUs and
who remain there for at least 2 days. All patients were
enrolled on the morning of ICU day 2. A detailed de-
scription of study procedures has been published else-
where [31,32]. All patients were phenotyped daily for
ALI/ARDS by two study physicians using the AECC def-
initions [35] and daily review of radiographs, arterial
blood gases, and the medical record.
For the 1,334 patients enrolled in VALID during the
study window and after approval by the Vanderbilt Univer-
sity Institutional Review Board (IRB# 110506), we retro-
spectively searched their blood bank records to determine
whether patients had received a RBC transfusion during
the 48 hours before VALID study enrollment. For the 433
patients who had RBC transfusions during this interval,
we recorded specific data regarding each unit of RBCs
transfused including the date of transfusion and the date
of collection from the donor. Storage duration of blood
was calculated as the time from donation to transfusion.
For inclusion in the sepsis group, patients had to have a
diagnosis of sepsis [36] on enrollment into VALID and
also have had received transfusion with RBCs in the 48hours before enrollment. Inclusion in the trauma group
required severe traumatic injury leading to ICU admission
and receipt of a blood transfusion with RBCs in the 48
hours before enrollment (Figure 1). Patients who were ad-
mitted to the ICU with severe traumatic injury who also
met criteria for severe sepsis at enrollment (n = 16) were
excluded from the analysis. All other critically ill patients
who received RBCs in the 48 hours before enrollment
were classified as nonsepsis, nontrauma. The window for
classifying patients with the presence or absence of ALI/
ARDS was 96 hours after enrollment/transfusion. Because
some patients developed ALI/ARDS 1 day or more after
enrollment and the fixed RBC exposure period of 48 hours
before enrollment may not account for all blood exposure
for this group, we conducted an additional sensitivity ana-
lysis by excluding patients who developed ALI/ARDS 1
day or more after enrollment.
Description of the storage of blood
All RBCs that were transfused were stored in the Vander-
bilt University Medical Center’s (VUMC) Blood Bank
according to guidelines established by the Food and Drug
Administration. Specifically, these units of blood were
leukoreduced using the Pall® Cell Processing Set (Ann
Arbor, MI) within 24 hours of collection and before
storage. The collection center tests 1% of all filter types
collected and manufactured. The quality control is moni-
tored each month and meets the American Academy of
Blood Banks requirement of 95% of products tested pass
the leukoreduction requirement. RBCs were not washed
nor were any antioxidant solutions added. The maximum
storage duration of RBCs at VUMC is 42 days.
Statistical analysis
We selected, a priori, patients with sepsis, as defined by
the consensus definition [36], on enrollment as our popu-
lation of interest. As the majority (88.5%) of ALI/ARDS in
this group occurred on the day of enrollment into VALID
and because the requirement for transfusion-related acute
lung injury to develop within 6 hours of transfusion [30]
may be too restrictive [37,38], we set an exposure period
of 48 hours before VALID enrollment for the analysis. The
primary outcome was development of ALI/ARDS during
the 96 hours after this exposure period. The same expos-
ure period and outcome windows were applied to the
trauma and nontrauma nonsepsis patients.
Transfusion data were summarized using the median
storage duration of all RBCs transfused in the 48 hours be-
fore enrollment into VALID. We also analyzed the max-
imum storage duration, defined as the storage duration of
the unit of RBCs with the longest storage duration trans-
fused to a patient during the exposure window.
Wilcoxon rank-sum tests were used to compare stor-
age durations between patients with and without acute
Figure 1 Flow diagram of patients included in each analysis.
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egorical variables. Logistic regression models were devel-
oped to investigate the associations between the potential
risk factors and the primary outcome of ALI/ARDS. Mul-
tiple imputation methods were used in the regression
models to account for missing data [39]. Penalized max-
imum likelihood estimation (PMLE) was used to account
for the potential impact of model overfitting [40]. A 300-
iteration bootstrapping was used to validate the PMLE
models. All analyses were performed using R 2.12.1 (R De-
velopment Core Team, Vienna, Austria). All tests were




Of the 433 patients enrolled in the VALID study who
had RBC transfusions during the 48 hours before enroll-
ment into the VALID study, 96 met diagnostic criteria
for sepsis on enrollment and comprised the study popu-
lation for the primary analysis (Table 1). The medianstorage duration of RBCs transfused to these 96 patients
was 23 days, interquartile range (IQR) 18–28 (Figure 2).
In these transfused patients with sepsis, 49 (51%) de-
veloped ALI/ARDS in the 96 hours after transfusion.
The median storage duration of RBCs transfused in the
patients who developed ALI/ARDS was significantly
longer (25 days, IQR 20–31) than the storage duration
in those who did not develop ALI/ARDS (21 days, IQR
15–27, p = 0.018). Similarly, the maximum storage dur-
ation of RBCs transfused to the patients who developed
ALI/ARDS was significantly longer (26 days, IQR 22–
33) than the maximum storage duration of RBCs trans-
fused to patients who did not develop ALI/ARDS (24
days, IQR 17–28, p = 0.01). The total number of units
transfused during the exposure window did not differ
between patients who developed ALI/ARDS (2 units,
IQR 2–3) and those who did not (2 units, IQR 2–4,
p = 0.303).
After controlling for known risk factors for the de-
velopment of ALI/ARDS, such as age, APACHE II score
on enrollment, smoking status, and number of units
Table 1 Baseline characteristics of patients with sepsis
Characteristic ALI/ARDS (n = 49) No ALI/ARDS (n = 47) p value
Age 53 (45, 62) 61 (52, 66.5) 0.021a
Female gender 46.9% (23) 42.6% (20) 0.666b
Current smoker 27.1% (13) 31.9% (15) 0.606b
ICU days 8 (5, 14) 6 (4, 11) 0.118a
Ventilator-free days 18 (1, 24) 25 (7.5, 28.0) 0.022a
Hospital days 17 (11, 26) 14 (9.5, 26.5) 0.325a
Baseline APACHE II score 29 (24, 32) 29 (22.5, 35) 0.751a
Blood median storage days 24.5 (20, 31) 21 (15, 26.8) 0.018a
Blood maximum storage days 26 (22, 33) 24 (17, 28) 0.01a
Number of Units Transfused 2 (2, 3) 2 (2, 4) 0.303a
Data given as median (25th percentile, 75th percentile) or percent (frequency) of patients.
aWilcoxon test; bPearson test.
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developing ALI/ARDS with exposure to blood of a longer
median storage duration (odds ratio (OR) 1.8 for the 75th
vs. 25th percentile of storage duration, 95% CI 1.07-3.04,
p = 0.028; Table 2; Figure 3) and longer maximum storage
duration (OR 2.0 for the 75th vs. 25th percentile of storage
duration, 95% CI 1.12-3.58, p = 0.02; Table 3). The sensi-
tivity analysis excluding 6 patients who developed ALI/Figure 2 Distribution of storage duration of packed red blood cells trARDS 1 day or more after enrollment showed similar re-
sults, with the odds ratios for median and maximum stor-
age duration remaining significant (OR 2.09, p = 0.018
and OR 2.29, p = 0.018, respectively).
Trauma patients
Of the 433 patients who received RBC transfusions 48
hours before enrollment in the VALID study, 176 patientsansfused to patients with sepsis.
Table 2 Median storage days and risk of ALI/ARDS in
patients with sepsis
Characteristics Odds ratio 95% CI p value
Median storage days (28 vs. 18) 1.8 1.07-3.04 0.028
Unit of transfused blood (4 vs. 2) 0.93 0.57-1.52 0.765
Age (65 vs. 47 yr) 0.62 0.37-1.04 0.069
Baseline APACHE II score (33 vs. 23) 0.87 0.51-1.5 0.612
Current smoker (yes vs. no) 0.93 0.42-2.07 0.863
Odds ratio for median storage days is the odds of developing ALI/ARDS in the
96 hours after transfusion for the patients receiving RBCs in the 75th compared
with 25th percentile of storage duration.
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which defined the study population for this secondary
analysis (Table 4).
In the trauma study population, 80 (45%) patients
were diagnosed with ALI/ARDS in the 4 days following
transfusion. The median storage duration of RBCs trans-
fused in the patients who developed ALI/ARDS was not
significantly longer (20 days, IQR 14–26) than the stor-
age duration in patients who did not develop ALI/ARDS
(20 days, IQR 14–27, p = 0.65). After controlling for age,
APACHE II score on enrollment, ISS score on enroll-
ment, smoking status, and number of units transfused,

























Figure 3 Percentage of sepsis patients developing ALI/ARDS in the 4
red blood cells. Grey bars represent the percentage of patients with sepsi
transfusion. Circles at the top and bottom represent cases and controls pla
and grey confidence band represent a fitted line showing the probability o
regression and the corresponding 95% confidence interval.with exposure to blood of a longer median storage
duration (OR 0.84 for the 75th vs. 25th percentile of stor-
age duration, CI 0.52-1.35, p = 0.46) nor with blood of
a longer maximum storage duration (OR 1.05 for the
75th vs. 25th percentile of storage duration, CI 0.72-1.83,
p = 0.57).Nonsepsis, nontrauma patients
Of the 433 patients enrolled who had RBC transfusions
during the VALID study, 125 patients were admitted to
an ICU for reasons other than sepsis or trauma, which
defined the study population for this secondary analysis
(Table 5).
In the nonsepsis, nontrauma study population, 13
(10.4%) patients were diagnosed with ALI/ARDS in the
4 days following transfusion. The median storage dur-
ation of RBCs transfused in the patients who developed
ALI/ARDS was not significantly longer (20 days, IQR
17–29) than the storage duration in patients who did
not develop ALI/ARDS (22 days, IQR 16–29, p = 1.0).
After controlling for age, APACHE II score on enroll-
ment, smoking status, and number of units transfused,
there was no increased risk of developing ALI/ARDS
with exposure to blood of a longer median storageays of Transfused Blood 
days after transfusion and median storage duration of transfused
s (n = 96) who developed ALI/ARDS during the 96 hours after
ced at their respective median age of transfused blood. The black line
f developing ALI/ARDS derived from the multivariable logistic
Table 5 Baseline characteristics of the nonsepsis,
nontrauma cohort
Characteristic ALI/ARDS No ALI/ARDS p value
(n = 13) (n = 112)
Age (yr) 56 (48, 59) 61 (49.8, 68) 0.191a
Female gender 69.2% (9) 43.8% (49) 0.081b
Current smoker 30.8% (4) 24.3% (27) 0.612b
ICU days 6 (3, 8) 5 (3, 9) 0.827a
Ventilator-free days 24 (16, 26) 26 (23, 27) 0.094a
Hospital days 16 (11, 21) 11 (7, 20.3) 0.337a
Baseline APACHE II score 26 (24, 29) 26 (22, 31) 0.711a
Blood median storage days 20 (17, 29) 22 (16, 29) 1a
Blood maximum storage days 26 (19, 35) 26.5 (20, 33) 0.907a
Number of units transfused 4 (2, 5) 4 (2, 8) 0.88a
Data given as median (25th percentile, 75th percentile) or percent (frequency)
of patients.
N is the number of nonmissing values.
aWilcoxon test; bPearson test.
Table 3 Maximum storage days and risk of ALI/ARDS in
patients with sepsis
Characteristics Odds ratio 95% CI p value
Maximum storage days (32 vs. 20) 2 1.12-3.58 0.02
Unit of transfused blood (4 vs. 2) 0.88 0.54-1.45 0.626
Age (65 vs. 47 yr) 0.64 0.38-1.07 0.089
Baseline APACHE II score (33 vs. 23) 0.89 0.52-1.54 0.676
Current smoker (yes vs. no) 0.86 0.39-1.91 0.717
Odds ratio for maximum storage days is the odds of developing ALI/ARDS in
the 96 hours after transfusion for the patients receiving RBCs in the 75th
compared with 25th percentile of maximum storage duration, defined as the
unit of RBCs of the longest storage duration received by a patient.
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storage duration, CI 0.36-2.42, p = 0.9) nor with blood
of a longer maximum storage duration (OR 1.07 for the
75th vs. 25th percentile of storage duration, CI 0.45-2.51,
p = 0.88).
Discussion
In this retrospective, observational study, there was a
significant association between the storage duration of
RBCs transfused to patients early in the course of sepsis
and the risk of developing ALI/ARDS up to 4 days after
exposure that was independent of the amount of blood
transfused. This association was not seen across other
critically ill patient populations, including patients with
severe traumatic injuries.
Although several reports have described an increased
risk of ALI/ARDS with transfusion of RBCs to critically ill
patients that is amplified by the number of units of RBCs
transfused [7-11], the current study is unique in that it de-
scribes an increased risk of ALI/ARDS in humans with in-
creasing storage duration of blood that is independent of
the number of units transfused. In rats and sheep exposedTable 4 Baseline characteristics of the trauma cohort
Characteristic ALI/ARDS No ALI/ARDS p value
(n = 80) (n = 96)
Age (yr) 51 (36, 63) 46 (29, 59) 0.094a
Female gender 28.8% (23) 24.0% (23) 0.471b
Current smoker 46.3% (31) 46.5% (40) 0.976b
ICU days 12 (7, 16) 8 (5, 13) 0.014a
Ventilator-free days 17 ( 12, 22) 21 (16, 24) <0.001a
Hospital days 16 (11, 24) 15 (10, 23) 0.281a
Baseline APACHE II score 27 (24, 31) 26 (22, 30) 0.035a
Baseline ISS score 34 (29, 41) 28 (19, 37) 0.011a
Blood median storage days 20 (14, 26) 20 (14, 27) 0.651a
Blood maximum storage days 25 (19, 32) 25 (19, 31) 0.583a
Number of units transfused 4 (2, 6) 4 (2, 9) 0.465a
Data given as median (25th percentile, 75th percentile) or percent (frequency)
of patients.
aWilcoxon test; bPearson test.to a “first-hit” (lipopolysaccharide, LPS) as a model of clin-
ical sepsis, transfusion of blood of a longer storage dur-
ation caused more severe lung inflammation and ALI
compared with fresh blood [27-29,41]. Increased lung in-
flammation and injury were only observed in those ani-
mals that received the dual insult of LPS and blood of a
longer storage duration; animals that were transfused with
blood of a longer storage duration without LPS exposure
had similar rates of ALI compared with controls. Con-
cordant with these animal studies, in the current study,
transfusion with blood of a longer storage duration was
only associated with ALI in patients with severe sepsis; the
association was not seen in severe trauma or critically ill
patients who had neither trauma nor sepsis. We did not
find an association between the number of units trans-
fused and ALI as others have reported [7-11], which may
be explained by our patient population receiving fewer
units of blood (median of 2 units RBCs per patient).
Transfusion-related acute lung injury (TRALI) is
strictly defined as the onset of ALI/ARDS within 6 hours
of a blood transfusion that is not explained by another
risk factor [30]. In the current study, we aimed to cap-
ture all ALI/ARDS events occurring after transfusion,
not just ALI/ARDS that met the strict TRALI definition.
We hypothesized that injurious mediators in stored
blood might potentiate acute lung injury in the setting
of other mediators of acute lung injury, such as sepsis
and that this potentiation would not be limited to a
6-hour window after transfusion. For this reason, we had
a 48-hour exposure window and included cases of ALI/
ARDS occurring as long as 4 days after the exposure,
although the majority (88.5%) of cases occurred in the
24 hours after enrollment. Our findings suggest that the
risk of ALI/ARDS associated with transfusion in patients
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that is used to define TRALI [37]. The numerous
changes that occur during the storage of RBCs [38] add
biologic plausibility to the observation that the potential
for poor outcomes is not limited to 6 hours after
transfusion.
The current study has several limitations. The retro-
spective observational design can only suggest association
rather than causation. Second, because the vast majority
of sepsis patients who developed ALI/ARDS met the cri-
teria for ALI/ARDS at the time of enrollment into the
VALID study on the morning of ICU day 2, we used a
fixed exposure period of 48 hours before enrollment for
ascertainment of RBC exposure; however, there were six
patients in the sepsis group who did not develop ALI/
ARDS until the days subsequent to enrollment and some
of these patients received transfusions beyond the expos-
ure period. As these units of RBCs were unaccounted for
in our primary analysis and to ensure these patients were
not significantly influencing our results, we repeated the
analysis without these patients and still found a significant
association. We only studied patients in VALID who had
received RBCs before enrollment, which limited our sam-
ple size to 96 sepsis patients, 176 trauma patients, and
125 nonsepsis nontrauma patients. Additionally, in the
nonsepsis nontrauma subset, there were only 13 patients
who developed ALI/ARDS, which significantly limits the
power to say anything definitive about this group of pa-
tients. Nonetheless, the association between storage dur-
ation and ALI/ARDS in patients with sepsis was robust
across multiple analyses. Finally, the difference in our
study in storage duration of RBCs transfused to patients
with sepsis was only 4 days and included transfusion of
RBCs of varying age to the same patient, whereas previ-
ously published work has focused on transfusion of RBCs
of a homogenous storage duration and had greater differ-
ences in the storage duration between groups [24,42]. The
relatively small difference in storage duration in our study
may suggest a less biologically meaningful finding; how-
ever, this may rather suggest that even small differences in
storage duration are meaningful when transfusing critic-
ally ill patients.
Our findings are not concordant with the results of a
randomized trial comparing transfusion of fresh blood to
blood of longer storage duration in critically ill patients,
which showed no difference in the development of ALI
between groups [42]. The disparity in results could be due
in part to that study being underpowered to detect a dif-
ference in this secondary outcome, a problem that might
be overcome by a larger, randomized trial currently under-
way [43]. In addition, animal models and our current find-
ings suggest that signals for increased risk of ALI/ARDS
after transfusion may be more robust in septic patient
populations rather than heterogeneous, critically ill patientpopulations as studied in this randomized trial that in-
cluded only 6 (6%) patients with sepsis. Although not fo-
cused on the development of ALI/ARDS, past studies of
trauma patients [7,22,25,44,45] showed that the storage
duration of RBCs was associated with worse clinical out-
comes, which is in contrast to our results. This difference
may potentially be explained by a markedly higher median
number of RBCs received in the past studies (12 units per
patient) [22] compared with our current study (median 4
units per patient in the trauma group). Finally, there is
existing data in trauma patients and patients having
undergone coronary artery bypass grafting that potential
signs of ALI/ARDS (respiratory insufficiency, increased
time on the ventilator and pneumonia) more often were
found in patients receiving blood of a longer storage dur-
ation [24,45]; however, the presence of ALI/ARDS in these
patients was not reported.
Our study has potential implications for future re-
search. There was a significant association not only with
the median storage duration of transfused blood but also
with the maximum storage duration of all units trans-
fused. These findings suggest that there might be in-
creased risk of morbidity and mortality with exposure to
even a single unit of RBCs with long storage duration.
The current study adds ALI/ARDS to a list of morbid-
ities associated with increasing storage duration of trans-
fused RBCs. Research focusing on the mechanisms that
drive the storage lesion and its end-organ effects will
provide us with targets for preventative therapy in pa-
tients unable to avoid transfusion. Larger, prospective
studies are needed to determine which patients (sepsis,
trauma, etc.) who required transfusion are at highest risk
from aged blood and what threshold delineates hazard-
ous storage duration. Only with additional prospective
clinical studies will we be able to create evidenced-based
guidelines for transfusion to limit both transfusion rates
and transfusion-related morbidity, such as ALI/ARDS.Conclusions
Transfusion of blood with longer median storage dur-
ation to patients with early sepsis is associated with a
higher risk of developing ALI up to 4 days after transfu-
sion, whereas this same association is not seen in pa-
tients with trauma or critically ill patients without sepsis
or trauma. This may suggest that the storage duration of
RBCs transfused to critically ill patients may have vari-
able effects depending on the underlying cause of a pa-
tient’s illness.Abbreviations
ICU: Intensive Care Unit; RBCs: Packed red blood cells; ALI: Acute lung injury;
ARDS: Acute Respiratory Distress Syndrome; VALID: Validating acute lung
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